The Gene and Cell Therapy: Development and Commercialization Summit 2019 is dedicated to the delivery of cost and quality efficient process development, manufacturing and commercialization of cell therapies.
The Gene and Cell Therapy: Development and Commercialization Summit 2019 covers topics such as:
- Emerging science and technologies to enhance cell and gene therapies development
- Optimized cell and gene therapies process development, manufacturing, cost, and quality efficiency
- Regulatory compliance to empower development and commercialization strategies of cell and gene therapies
- Advanced analytical approaches to improve quality control and real time release
- Robust supply chain design for precision medicine therapies
The Gene and Cell Therapy: Development and Commercialization Summit 2019 brings together attendees involved or interested in:
- Bioprocessing
- Advanced Therapy Production
- Cell Therapy
- CAR-T
- CMC
- Cellular Therapy
- Immune Deficiencies
- GMP
- Immunotherapy
- Immunology
- Medical
- Manufacturing
- Process Development
- Precision Medicine
- Regulatory
- R&D
- Tissue Therapy
- Stem Cell
- Analytical
- Cell Engineering
- Biotherapeutics
- Clinical Development
- Cellular Immunotherapy
- Health Economics
- Gene Therapy
- Immunology Chemistry
- Immuno-Oncology
- Market Access
- Legal/IP
- Pricing
- Oncology
- Regenerative Medicine
- Quality Control
- Supply Chain
- Sales
